Evommune, Inc. (EVMN)
12.45
-0.21
(-1.66%)
USD |
NYSE |
Sep 01, 12:59
Evommune Cash and Short Term Investments (Quarterly) : 200.79M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 200.79M |
| March 31, 2026 | 211.46M |
| December 31, 2025 | 149.20M |
| Date | Value |
|---|---|
| September 30, 2025 | 76.06M |
| June 30, 2025 | 86.80M |
| March 31, 2025 | 48.41M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| MapLight Therapeutics, Inc. | 304.72M |
| Mineralys Therapeutics, Inc. | 661.41M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |